以未转换记忆B细胞中的IGHV4-34对系统性红斑狼疮进行分层
本研究纳入系统性红斑狼疮患者,对外周血B细胞亚群进行RNA测序分析IGHV基因使用,计算未转换记忆B细胞中IGHV4-34克隆型频率。结果显示该频率与疾病活动度相关,ROC分析确定区分低补体患者的阈值,高使用率组关节炎、血尿、蛋白尿、皮疹、发热更多且LLDAS、SLEDAI 2000及医师整体评估更差;他克莫司治疗达LLDAS者中高使用率组复发率更高。
要点
- 未转换记忆B细胞IGHV4-34使用率与SLE疾病活动度显著相关。
- ROC分析确定未转换记忆B细胞IGHV4-34使用率区分低补体患者的阈值。
- 高使用率组关节炎、血尿、蛋白尿、皮疹、发热更多,LLDAS等指标更差。
核心结论
- 未转换记忆B细胞中IGHV4-34使用率是SLE的潜在生物标志物,并可用于患者分层。
研究设计与样本
- 研究纳入SLE患者并采集外周血,将B细胞分选为初始B细胞、未转换记忆B细胞、转换记忆B细胞、双阴性B细胞和浆母细胞,行RNA测序分析IGHV基因使用并计算使用IGHV4-34的克隆型频率。
- 采用回归分析分析IGHV4-34使用与临床特征的交互作用,采用受试者工作特征(ROC)分析确定按IGHV4-34使用率对SLE患者分层的阈值。
主要发现
- 未转换记忆B细胞中IGHV4-34使用率与疾病活动度有显著关联。
- ROC曲线分析得出未转换记忆B细胞IGHV4-34使用率区分低补体水平患者与其他患者的阈值。
- 未转换记忆B细胞中IGHV4-34高使用率与关节炎、血尿、蛋白尿、皮疹和发热相关。
- 高IGHV4-34使用率组在达到狼疮低疾病活动状态(LLDAS)、SLEDAI 2000评分和医师整体评估评分方面表现更差。
- 在他克莫司治疗下达到LLDAS的患者中,未转换记忆B细胞IGHV4-34高使用率者复发率更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: SLE is an autoimmune disease characterized by the production of autoantibodies. Antibody affinities are defined by immunoglobulins, which include the immunoglobulin heavy-chain variable region (IGHV) genes, but the relationship between SLE and IGHV has not been fully elucidated. This study aimed to investigate the association between clinical features of SLE and IGHV. METHODS: We recruited SLE patients and collected their peripheral blood. B cells from SLE patients were sorted into naïve B cells, unswitched memory (USM) B cells, switched memory B cells, double-negative B cells and plasmablasts. RNA-seq was performed to analyse IGHV gene usage, calculating the frequency of clonotypes that use IGHV4-34. The interactions between IGHV4-34 usage and clinical features were analysed by regression analysis, and the threshold for stratifying SLE patients by IGHV4-34 usage was determined by receiver operating characteristic (ROC) analysis. RESULTS: IGHV4-34 usage in USM B cells had a significant association with disease activity. ROC curve analysis revealed the threshold of IGHV4-34 usage in USM B cells which distinguished patients with low complement levels from the other patients. High IGHV4-34 usage in USM B cells was associated with arthritis, haematuria, proteinuria, rash and fever. Achievement of a lupus low disease activity state (LLDAS), SLEDAI 2000 score and physician global assessment score showed worse values in the high IGHV4-34 usage group. Among those who achieved LLDAS under tacrolimus treatment, patients with high IGHV4-34 usage in USM B cells had a higher flare rate. CONCLUSION: IGHV4-34 usage in USM B cells is a potential biomarker of SLE and for patient stratification.
引用
- Ushijima TS, Teruya H, Abe T, et al. Stratification of systemic lupus erythematosus with IGHV4-34 in unswitched memory B cells. Rheumatology (Oxford). 2025. PMID: 40650930. doi:10.1093/rheumatology/keaf386
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。